EDIT vs MAS
Editas Medicine Inc (EDIT) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
EDIT currently screens at market cap $375.2M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the EDIT and MAS stock pages for the full models.
Not investment advice.